(19)
(11) EP 1 951 735 A1

(12)

(43) Date of publication:
06.08.2008 Bulletin 2008/32

(21) Application number: 06828973.5

(22) Date of filing: 07.11.2006
(51) International Patent Classification (IPC): 
C07H 17/08(2006.01)
A61K 31/7048(2006.01)
(86) International application number:
PCT/EP2006/010731
(87) International publication number:
WO 2007/054295 (18.05.2007 Gazette 2007/20)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR

(30) Priority: 09.11.2005 WO PCT/EP2005/012038

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • ELDER, John, Stephen
    Harlow Essex CM19 5AW (GB)
  • FORREST, Andrew, Keith
    Harlow Essex CM19 5AW (GB)
  • HUNT, Eric
    Harlow Essex CM19 5AW (GB)

(74) Representative: Morris, Miriam Elizabeth 
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NEW 4*-SUBSTITUTED ERYTHROMYCIN DERIVATIVE